Long-COVID Rate May Be Higher With Rheumatic Diseases

The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients with rheumatic disease.
Medscape Medical News

source https://www.medscape.com/viewarticle/991466?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?